Australia markets closed

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.65+0.65 (+3.42%)
At close: 04:00PM EDT
19.65 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-152,631
-152,631
-135,840
-130,466
-89,625
Depreciation & amortisation
849
849
759
558
194
Stock-based compensation
28,082
28,082
26,318
23,579
12,807
Change in working capital
7,819
7,819
-2,982
-3,224
6,384
Other working capital
-124,992
-124,992
-110,688
-105,698
-72,001
Other non-cash items
477
477
73
399
-
Net cash provided by operating activities
-124,824
-124,824
-110,062
-104,551
-69,830
Cash flows from investing activities
Investments in property, plant and equipment
-168
-168
-626
-1,147
-2,171
Purchases of investments
-409,824
-409,824
-270,655
-445,657
-320,963
Sales/maturities of investments
425,549
425,549
303,908
319,969
223,198
Net cash used for investing activities
15,557
15,557
32,627
-126,835
-99,936
Cash flows from financing activities
Debt repayment
0
0
0
-7,250
-250
Common stock issued
93,577
93,577
24,721
0
459,335
Other financing activities
-
-
-575
-611
-
Net cash used provided by (used for) financing activities
94,783
94,783
38,565
-3,435
469,334
Net change in cash
-14,484
-14,484
-38,870
-234,821
299,568
Cash at beginning of period
51,802
51,802
90,672
325,703
26,135
Cash at end of period
37,318
37,318
51,802
90,882
325,703
Free cash flow
Operating cash flow
-124,824
-124,824
-110,062
-104,551
-69,830
Capital expenditure
-168
-168
-626
-1,147
-2,171
Free cash flow
-124,992
-124,992
-110,688
-105,698
-72,001